Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma.

Autor: Tian M, Wei JS, Shivaprasad N, Highfill SL, Gryder BE, Milewski D, Brown GT, Moses L, Song H, Wu JT, Azorsa P, Kumar J, Schneider D, Chou HC, Song YK, Rahmy A, Masih KE, Kim YY, Belyea B, Linardic CM, Dropulic B, Sullivan PM, Sorensen PH, Dimitrov DS, Maris JM, Mackall CL, Orentas RJ, Cheuk AT, Khan J
Jazyk: angličtina
Zdroj: Cell reports. Medicine [Cell Rep Med] 2024 May 21; Vol. 5 (5), pp. 101586. Date of Electronic Publication: 2024 May 09.
DOI: 10.1016/j.xcrm.2024.101586
Databáze: MEDLINE